Search results for "Duodenectomy"

showing 10 items of 26 documents

Treatment of tumors of the pancreatic head with suspected but unproved malignancy: is a nihilistic approach justified?

1999

The aim of the present prospective observational study was to evaluate the accuracy of preoperative imaging studies and the outcome of patients after pancreaticoduodenectomy for suspected but unproved malignancy. Pancreaticoduodenectomy was performed in 186 patients with a suspected but histologically unproved malignancy of the pancreatic head: 86 with a ductal pancreatic carcinoma, 56 with a periampullary tumor, 18 with a cystadenocarcinoma, 13 with a rare malignant tumor or a metastasis, and 13 with a benign tumor. An accurate differentiation between a ductal pancreatic carcinoma and a nonductal tumor or a benign tumor was neither possible with tumor marker CA 19-9 nor with diagnostic ima…

AdultDiagnostic ImagingMalemedicine.medical_specialtyAmpulla of VaterPancreatic diseaseAdolescentCA-19-9 Antigenmedicine.medical_treatmentCommon Bile Duct NeoplasmsCystadenocarcinomaMalignancyBenign tumorPancreaticoduodenectomyPancreatic tumormedicineCarcinomaHumansProspective StudiesCystadenocarcinomaTumor markerAgedAged 80 and overbusiness.industryPancreatic DuctsMiddle Agedmedicine.diseasePancreaticoduodenectomyPancreatic NeoplasmsSurvival RateTreatment OutcomeDiagnostic Techniques SurgicalCarcinoma Squamous CellSurgeryFemaleRadiologybusinessFollow-Up StudiesWorld journal of surgery
researchProduct

Utility of CT in the diagnosis of pancreatic fistula after pancreaticoduodenectomy in patients with soft pancreas.

2009

OBJECTIVE: The purpose of this study was to evaluate the sensitivity and specificity of routine performance of CT on postoperative day 7 in patients at high risk of pancreatic fistula after pancreaticoduodenectomy. MATERIALS AND METHODS: Two radiologists analyzed images from CT examinations of 50 patients with soft pancreas 7 days after pancreaticoduodenectomy. Pancreatic fistula was defined at CT as a fluid collection close to the pancreaticogastric or pancreaticojejunal anastomosis. Clinicobiologic criteria for the diagnosis of pancreatic fistula were drain output of any measurable volume of fluid on or after postoperative day 3 that had an amylase content more than three times the serum …

AdultMalePancreas Computed Tomographymedicine.medical_specialtyAdolescentmedicine.medical_treatmentIohexolContrast MediaSerum amylaseSensitivity and SpecificityPancreaticoduodenectomyPancreatic FistulaPostoperative ComplicationsPredictive Value of TestsRisk FactorsHospital dischargeMedicineHumansRadiology Nuclear Medicine and imagingIn patientAgedAged 80 and overbusiness.industryPancreatic DiseasesGeneral MedicineMiddle AgedPancreaticoduodenectomymedicine.diseasePancreaticojejunal anastomosismedicine.anatomical_structurePancreatic fistulaPredictive value of testsFemaleRadiologybusinessPancreasTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Total pancreatectomy: indications, operative technique, and results: a single centre experience and review of literature.

2010

The aims of this study were to identify the indications to perform a total pancreatectomy and to evaluate the outcome and quality of life of the patient who underwent this operation. A retrospective analysis of a prospective database, regarding all the patients who underwent total pancreatectomy from January 2006 to June 2009, was carried out. Perioperative and outcome data were analyzed in two different groups: ductal adenocarcinoma (group 1) and non-ductal adenocarcinoma (group 2). Twenty (16.9%) total pancreatectomies out of 118 pancreatic resections were performed. Seven (35.0%) patients were affected by ductal adenocarcinoma (group 1) and the remaining 13 (65.0%) by pancreatic diseases…

AdultMalemedicine.medical_specialtyPancreatic diseaseSURGERYmedicine.medical_treatmentNeuroendocrine tumorsTOTAL PANCREATECTOMYGastroenterologyPancreatectomyPostoperative ComplicationsTUMORPancreatic cancerInternal medicinemedicineHumansAgedPANCREASbusiness.industryPerioperativeMiddle Agedmedicine.diseasePancreaticoduodenectomyPancreatic cancer Pylorus preserving Spleen preservingSurgeryPancreatic NeoplasmsSettore MED/18 - Chirurgia GeneralePancreatectomyCHRONIC PANCREATITISPancreatitisAdenocarcinomaFemalebusinessUpdates in surgery
researchProduct

Non-arbitrary minimum threshold of yearly performed pancreatoduodenectomies: National multicentric study

2021

Abstract Background Annual hospital volume of pancreatoduodenectomies could influence postoperative outcomes. The aim of this study is to establish with a non-arbitrary method the minimum threshold of yearly performed pancreatoduodenectomies in order to improve several postoperative quality outcomes. Method Prospective follow-up of patients submitted to pancreatoduodenectomy in participating hospitals during 1 year. The influence of hospital volume on quality outcomes was analyzed by univariable and multivariable models. The minimum threshold of yearly performed pancreatoduodenectomies to improve outcomes was established by Akaike’s information criteria. Results Data from 877 patients opera…

AdultMalemedicine.medical_specialtyPostoperative death030230 surgeryPancreaticoduodenectomyYoung Adult03 medical and health sciencesPostoperative Complications0302 clinical medicineHospital volumeRisk FactorsmedicineHumansAgedQuality of Health CareAged 80 and overbusiness.industryMargins of ExcisionLength of StayMiddle AgedHospitalsPancreatic NeoplasmsSpain030220 oncology & carcinogenesisMultivariate AnalysisEmergency medicineLymph Node ExcisionFemaleSurgerybusinessSurgery
researchProduct

Robotic pancreatic surgery: old concerns, new perspectives.

2018

Background: Described for the first time in 2003, the robotic pancreatic surgery shows interesting results. The evaluation of post-operative outcomes is necessary once we describe an innovative surgical approach. Methods: We have performed a retrospective analysis of a prospectively maintained database on robotic pancreatic surgery including malignant and benign indications for surgery. Results: A total of 50 consecutive patients underwent robotic pancreatic surgery (26 pancreatico duodenectomy and 24 distal pancreatectomy) between January 2012 and July 2015 in a single centre. The overall operative time was 425 (390–620) min. In a subgroup of highly selected malignant tumours, we were able…

AdultMalemedicine.medical_specialtyRobotic Surgical Proceduremedicine.medical_treatmentRobotic pancreatic surgeryOperative Time030230 surgeryPancreatic surgeryPancreaticoduodenectomy03 medical and health sciences0302 clinical medicinepancreatic fistulaPancreatectomyPostoperative ComplicationsRobotic Surgical ProceduresRetrospective StudieMedicineHumansdistal pancreatectomypostoperative complicationAgedRetrospective Studiesbusiness.industryGeneral surgeryPancreatic DiseasesGeneral MedicineMiddle Agedmedicine.diseasePancreaticoduodenectomySurvival RateTreatment OutcomePancreatic fistula030220 oncology & carcinogenesisSurgeryFemalePancreatic DiseasebusinessDistal pancreatectomyHumanActa chirurgica Belgica
researchProduct

Whipple's pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center

2015

Abstract Introduction Pancreatic cancer is the fourth cause of death from cancer in Western countries. The radical surgical resection is the only curative option for this pathology. The prevalence of this disease increases with age in population. The causes of pancreatic cancer are unknown, but we consider risk factors like smoke and tobacco usage, alcohol consumption coffee, history of diabetes or chronic pancreatitis. In this study we report our experience in the treatment of resectable pancreatic cancer and periampullary neoplasms with particular attention to evaluate the evolution of surgical technique and the clinical postoperative outcomes. Methods In our Department between January 20…

AdultMalemedicine.medical_specialtyWhipple proceduremedicine.medical_treatmentPopulationPancreaticoduodenectomyPancreatic FistulaPancreatectomyPostoperative ComplicationsRisk FactorsPancreatic cancerMedicineHumanseducationAgedAged 80 and overeducation.field_of_studyGastric emptyingbusiness.industryClinical outcomePostoperative pancreatic fistulaGeneral surgeryAnastomosis SurgicalCancerGeneral MedicinePerioperativePancreatic cancerLength of StayMiddle AgedPancreaticoduodenectomymedicine.diseaseSurgeryPancreatic NeoplasmsClinical outcomes; Pancreatic cancer; Pancreaticoduodenectomy; Postoperative pancreatic fistula; Whipple procedure; SurgerySettore MED/18 - Chirurgia GeneralePancreatic fistulaPancreatitisFemaleSurgerybusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Factors Influencing Morbidity and Mortality after Pancreaticoduodenectomy: Critical Analysis of 221 Resections

1999

A critical analysis of morbidity and mortality for pancreatico-duodenectomy was performed on 221 patients. During the 1960s and 1970s, the morbidity and mortality for pancreaticoduodenectomy were so high that many thought the operative procedure ought to be abandoned. During the 1980s, however, many centers reported mortality rates around 5% and a morbidity of 25% to 35%. Others still reported a mortality of more than 10% and a morbidity of up to 65%. The reasons for these discrepancies are of major interest. In a prospective case-control study 760 patients with malignant and benign diseases of the pancreas were treated in our hospital between September 1, 1985 and April 30, 1997. In 221 ca…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentBlood Loss SurgicalPancreaticoduodenectomyPostoperative ComplicationsmedicineHumansProspective StudiesSurvival rateAgedAged 80 and overPancreatic ductPortal Veinbusiness.industryPatient SelectionGeneral surgeryMortality ratePancreatic DuctsPancreatic DiseasesBilirubinMiddle AgedVascular surgeryPancreaticoduodenectomyCardiac surgerySurgeryPancreatic NeoplasmsSurvival Ratemedicine.anatomical_structureCardiothoracic surgeryCase-Control StudiesRegression AnalysisFemaleSurgeryClinical CompetencebusinessFollow-Up StudiesAbdominal surgeryWorld Journal of Surgery
researchProduct

Randomized clinical trial of pancreaticogastrostomy versus pancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduo…

2013

Abstract Background Anastomotic leakage of pancreaticojejunostomy (PJ) remains the single most important source of morbidity after pancreaticoduodenectomy (PD). The primary aim of this randomized clinical trial comparing PG with PJ after PD was to test the hypothesis that invaginated PG would result in a lower rate and severity of pancreatic fistula. Methods Patients undergoing PD were randomized to receive either a duct-to-duct PJ or a double-layer invaginated PG. The primary endpoint was the rate of pancreatic fistula, using the definition of the International Study Group on Pancreatic Fistula. Secondary endpoints were the evaluation of severe abdominal complications (Clavien–Dindo grade …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentGastroenterologyPancreaticoduodenectomylaw.inventionPancreatic FistulaPancreatectomyPostoperative ComplicationsRandomized controlled triallawInternal medicinemedicineClinical endpointHumansProspective StudiesProspective cohort studyAgedAged 80 and overGastrostomybusiness.industryIncidence (epidemiology)Length of StayMiddle Agedmedicine.diseasePancreaticoduodenectomyGastrostomySurgeryTreatment OutcomePancreatic fistulaPancreatectomyDrainageFemaleSurgerybusinessBritish Journal of Surgery
researchProduct

Biliopancreatic Endoscopy in Altered Anatomy

2021

Background and Objectives: Anatomical post-surgical alterations of the upper gastrointestinal (GI) tract have always been challenging for performing diagnostic and therapeutic endoscopy, especially when biliopancreatic diseases are involved. Esophagectomy, gastrectomy with various reconstructions and pancreaticoduodenectomy are among the most common surgeries causing upper GI tract alterations. Technological improvements and new methods have increased the endoscopic success rate in these patients, and the literature has been rapidly increasing over the past few years. The aim of this systematic review is to identify evidence on the available biliopancreatic endoscopic techniques performed i…

Endoscopic ultrasoundMedicine (General)medicine.medical_treatmentCochrane LibraryEndosonographyERCPR5-920GastrectomyMedicinedifficult biliary stonesHumansProspective StudiesRetrospective StudiesCholangiopancreatography Endoscopic RetrogradeEndoscopic retrograde cholangiopancreatographyUSmedicine.diagnostic_testbusiness.industryinterventional EUSRetrospective cohort studyGeneral MedicineAnatomyPancreaticoduodenectomyEndoscopyEsophagectomyTherapeutic endoscopyFNBSystematic Reviewbusinessbiliopancreatic endoscopyCH-EUSMedicina
researchProduct

Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer

2020

AbstractImmune suppressing molecule CD73 is overexpressed in various cancers and associated with poor survival. Little is so far known about the predictive value of CD73 in pancreatic ductal adenocarcinoma (PDAC). The purpose of this study was to investigate the prognostic significance of CD73 in PDAC. The study material consisted of 110 radically treated patients for PDAC. Tissue microarray blocks were constructed and stained immunohistochemically using CD73 antibody. Staining intensity and numbers of stained tumour cells, inflammatory cells, stroma, and blood vessels were assessed. High-level CD73 expression in tumour cells was positively associated with PD-L1 expression, perineural invas…

Male0301 basic medicinePathologyentsyymitDatabases Factualpancreatic cancerPerineural invasionB7-H1 Antigen0302 clinical medicineRisk FactorsTumor MicroenvironmentMedicine5'-NucleotidasehaimasyöpäAged 80 and overTissue microarraybiologyGeneral MedicineMiddle AgedPrognosisTreatment OutcomesyöpäsolutChemotherapy AdjuvantimmuunijärjestelmäLymphatic Metastasis030220 oncology & carcinogenesisOriginal ArticleFemaleAntibodyCarcinoma Pancreatic DuctalPD-L1Cell typemedicine.medical_specialtyMicroenvironmentGPI-Linked ProteinsRisk AssessmentPancreaticoduodenectomyPathology and Forensic Medicine03 medical and health sciencesLymphocytes Tumor-InfiltratingPancreatectomyImmune systemStromaPancreatic cancerPD-L1Biomarkers TumorHumansMolecular BiologyAgedNeoplasm Stagingbusiness.industryennusteetPancreatic cancerCell Biologymedicine.disease3126 Surgery anesthesiology intensive care radiologymicroenvironmentPancreatic Neoplasms030104 developmental biologybiology.proteinCD73prognosisNeoplasm Gradingbusiness
researchProduct